Company announcement No. 23/2025                                                 7 April 2026 Reduction of Share Capital in Netcompany Group A/S At the Annual General Meeting on 5 March 2026, a decision was passed to reduce the share capital by DKK 1,500,000 by cancelling 1,500,000 treasury shares. No objections to the share capital reduction have been received. Thus, registration of the share capital reduction was made by the Danish Business Authority on 7 April 2025. Following the cancellation of the 1,500,000 shares, the share capital of Netcompany Group A/S has a current nominal value of DKK 46,000,000 divided into 46,000,000 shares with a face value of DKK 1, corresponding to a total of 46,000,000 voting rights. Additional informationFor additional information, please contact: Netcompany Group A/SThomas Johansen, CFO, + 45 51 19 32...

CloverMint averaged 7.5% gross annualized over two months of private live testing; public trial expected in early April Jacksonville, FL, April 07, 2026 (GLOBE NEWSWIRE) — Everything Blockchain Inc. (OTC: EBZT) has entered into agreements for 10% to 15% ownership stakes in five early-stage companies across AI and crypto, selected from more than 30 reviewed opportunities. All agreements remain subject to final diligence and closing conditions. The portfolio construction milestone is part of EBZT’s strategy to become a public-market vehicle for early-stage technology exposure. The Company combines internal product development with strategic ownership stakes in private businesses, giving shareholders access to multiple emerging opportunities through a single publicly traded company. Separately, the Company’s stablecoin...

TORONTO, April 07, 2026 (GLOBE NEWSWIRE) — Visionary Holdings Inc. (Nasdaq: GV) (the “Company”) today announced that it received a notification letter (the “Deficiency Letter”) from the Nasdaq Listing Qualifications Department on April 2, 2026, indicating that the Company is not in compliance with the continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1). As described in the Deficiency Letter, the Company has not timely filed a Form 6-K containing its interim financial statements, including an unaudited balance sheet and income statement as of the end of its second fiscal quarter (the “Required Filing”). As a result, the Company is not currently in compliance with Nasdaq’s periodic reporting requirements for continued listing. In accordance with Nasdaq Listing Rules, the Company has been granted a period of...

New entity strengthens SunHydrogen’s ties with Japan’s leading solar hydrogen research community and gives an ongoing scientific collaboration a permanent structure. CORALVILLE, IA, April 07, 2026 (GLOBE NEWSWIRE) — SunHydrogen, Inc. (OTCQB: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using only sunlight and water, today announced the formation of SunHydrogen Japan GK, a new subsidiary led by Dr. Taro Yamada. The entity formalizes a collaboration that has already contributed directly to the company’s technical progress. SunHydrogen’s core operations and technology development remain rooted in Coralville, Iowa. The team there continues to drive the company’s progress, from the early development of its hydrogen panel technology to the outdoor pilot system now testing at the ProtoHub in Austin....

HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCQB: HYOR), a developer of waste-to-fuel and advanced energy technologies, today announced that MO.RE.DA. Oils, Lda, a Portuguese industrial company, has joined the HyOrc Start Green Fuels, Lda joint venture, assuming the rights and obligations previously held by Start Lda. The ownership structure of the joint venture is as follows:HyOrc Corporation – 50% MO.RE.DA. Oils, Lda – 50%MO.RE.DA. Oils owns an established industrial facility in Guilhabreu, Vila do Conde, Portugal, which is expected to host HyOrc’s planned Porto waste-to-methanol pilot plant. The facility already holds an industrial operating permit, providing the project with a significant regulatory advantage. Because the site is already licensed for industrial activity, the partners expect the project...

TORONTO, Ontario and HAIFA, Israel and POMPANO BEACH, Florida, April 07, 2026 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) and BioXtek Inc. (“BioXtek”) today announced that Exo-Top Inc., NurExone’s wholly owned U.S. subsidiary, (“Exo-Top” and together, with BioXtek, the “Parties”) has entered into a non-binding letter of intent (the “LOI”) with BioXtek, a Florida-based company, to explore a strategic partnership in the field of regenerative therapies for exosome manufacturing and commercialization. The Parties intend to negotiate a strategic partnership to support U.S. Good Manufacturing Practice (“GMP”) manufacturing, clinical supply, and potential commercialization of bone marrow–derived mesenchymal stem cell (“MSC”) exosomes in the U.S. and international markets....